search
Back to results

Pharyngocise Dose Response Study

Primary Purpose

Dysphagia

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Pharyngocise
Sponsored by
University of Florida
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Dysphagia focused on measuring swallowing disorders, swallowing therapy, head neck cancer, oropharyngeal dysphagia

Eligibility Criteria

21 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Head/Neck cancer of the oropharyngeal or adjacent regions, confirmed by clinical history and exam, with positive cross sectional imaging studies and histopathological biopsy excluding other pathology.
  2. Planned external beam radiation therapy
  3. No previous history of non-oral feeding for cancer related illness
  4. Able to undergo MRI imaging scan
  5. Patient and physician agreement to enter the study

Exclusion Criteria:

  1. Planned extensive surgical intervention
  2. Existence of a co-existing neurological or medical disorder known to cause dysphagia
  3. Prior radiotherapy or surgery to the head / neck region that could contribute to dysphagia.
  4. Previous swallowing therapy within four weeks of randomization
  5. Gross tumor involvement of the oral and pharyngeal muscles obviating adequate MRI measurements of the majority of muscles of interest.

Sites / Locations

  • Shands Cancer Center, University of Florida

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

No Intervention

Experimental

Active Comparator

Arm Label

Usual care

High Intensity Pharyngocise

Low Intensity Pharyngocise

Arm Description

Control (Usual care) group in which patients will receive swallowing and prescribed dietary intervention during the radiotherapy period prescribed by the attending physician.

Patients receive twice daily swallowing intervention by a speech language pathologist, consisting of the battery of isometric / isotonic exercises.

Patients will receive a one time only swallowing intervention session by a speech language pathologist, instructing them in the battery of isometric / isotonic exercises plus a home practice instruction digital video tape to support self directed practice of this program at home.

Outcomes

Primary Outcome Measures

Change in T2 Weighted Magnetic Resonance Imaging
T2 Weighted Magnetic Resonance Imaging (MRI) to quantify baseline muscle parameters in the oral cavity and pharynx. The regions of interest will be identified on images using axial and coronal planes. Information regarding the muscle volume, composition (fat Vs muscle Vs edema) as reflected by the signal intensity.
Clinical swallowing Ability
Swallowing ability and method/ type of dietary intake, e.g. Functional Oral Intake Scale score [F.O.I.S] over the study period

Secondary Outcome Measures

Weight
Weight and Body Mass Index will be calculated.
Psychosocial functioning
Domain assessments for, quality of life, pain,and fatigue using the Functional Assessment of Cancer Therapy - Head and Neck (FACT-H/N), Pain Disability Index (PDI), Functional Assessment of Cancer Therapy - Anemia (FACT-An) scale, Multidimensional Fatigue Symptom Inventory (MFSI), Profiles of Mood Scale (POMS) and Center for Epidemiologic Studies Depression Scale(CESD).
Instrumental swallowing evaluation
Range of swallowing biomechanics measured from endoscopic and fluorographic evaluations.
Swallowing Quality of Life
Patient perception of effect of swallowing disability - Swallowing Quality of Life (SWAL QOL) score during the study period.

Full Information

First Posted
January 7, 2011
Last Updated
January 4, 2012
Sponsor
University of Florida
Collaborators
American Cancer Society, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT01279837
Brief Title
Pharyngocise Dose Response Study
Official Title
Muscle Preservation and Swallow Function Following Radiotherapy: A Dose Response Study
Study Type
Interventional

2. Study Status

Record Verification Date
January 2011
Overall Recruitment Status
Completed
Study Start Date
June 2006 (undefined)
Primary Completion Date
October 2011 (Actual)
Study Completion Date
December 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Florida
Collaborators
American Cancer Society, Inc.

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
In this study supported by an American Cancer Society grant, the investigators are evaluating two levels of swallowing exercise intensity on the maintenance of swallowing muscles and their function in Head/Neck cancer patients undergoing radiotherapy. Patients in this study are randomly placed into different exercise groups and provided with exercises to perform daily during their radiation treatment. Their progress, diet management and swallowing ability are monitored throughout the treatment period and followed up until 3 months after radiation treatment. In addition to the daily treatment details, the patients perception of their swallowing ability and concerns about their health and treatment are also measured. This clinical trial will help to refine a previously investigated simple exercise package and provide a program of intervention that can help prevent medically related complications of swallowing difficulty (e.g. pneumonia, dehydration, prolonged tube feeding), and improve the ability to eat for patients with head / neck cancer. Ultimately it is hoped that this form of exercise therapy will help reduce the costs (personal and financial) to the patient, caregivers and community.
Detailed Description
In an earlier pilot study, a regime of simple swallowing exercises was identified as useful in maintaining oropharyngeal muscle characteristics as measured by T2 weighted Magnetic Resonance Imaging (MRI) and produced a trend toward improved function for swallowing in patients undergoing radiotherapy for head and neck cancer. The purpose of this current study is to evaluate the dose response of two levels of swallowing exercise intensity on the maintenance of muscle composition and function for swallowing in Head/Neck cancer patients undergoing radiotherapy. HYPOTHESIS: A program of intensive swallowing exercise (Pharyngocise) will maintain muscle function in the oral cavity and pharynx during radiotherapy, preserving or supporting swallowing function in Head/Neck cancer patients. STUDY DESIGN: 130 patients with Head/Neck cancer, confirmed by clinical history and exam, will be recruited over a 4 year period. All subjects will undergo an initial baseline work up, including a standardized clinical and instrumental swallowing evaluation, psychosocial scales, nutritional exam, and T2 weighted MRI prior to the first radiation therapy. Subjects will be randomized into 1 of 3 groups: Group A: Usual care (control) group - patients will receive swallowing and prescribed dietary intervention during the radiotherapy period prescribed by the attending physician. Group B: High intensity pharyngocise treatment group - patients will receive twice daily swallowing intervention by a speech language pathologist, consisting of the battery of isometric/isotonic exercises. Group C: Low intensity pharyngocise treatment group - patients will receive a single instructional exercise session on the isometric/isotonic exercises from a Speech Language Pathologist and a practice tape to support home practice of the exercises. All patients will be treated for approximately 6 weeks and followed for 3 months post treatment. Baseline assessments will be repeated. In addition, daily treatment details, patients perception of current swallowing ability and progress in therapy will be recorded by the Speech Pathologist. Participants will be independently monitored throughout the treatment period by researcher blind to the treatment group assigned, via weekly phone interview sessions. Compliance with the treatment techniques, and the occurrence of any negative endpoints such as occurrence of aspiration pneumonia will be recorded.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dysphagia
Keywords
swallowing disorders, swallowing therapy, head neck cancer, oropharyngeal dysphagia

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 2, Phase 3
Interventional Study Model
Factorial Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
130 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Usual care
Arm Type
No Intervention
Arm Description
Control (Usual care) group in which patients will receive swallowing and prescribed dietary intervention during the radiotherapy period prescribed by the attending physician.
Arm Title
High Intensity Pharyngocise
Arm Type
Experimental
Arm Description
Patients receive twice daily swallowing intervention by a speech language pathologist, consisting of the battery of isometric / isotonic exercises.
Arm Title
Low Intensity Pharyngocise
Arm Type
Active Comparator
Arm Description
Patients will receive a one time only swallowing intervention session by a speech language pathologist, instructing them in the battery of isometric / isotonic exercises plus a home practice instruction digital video tape to support self directed practice of this program at home.
Intervention Type
Behavioral
Intervention Name(s)
Pharyngocise
Intervention Description
swallowing intervention by a speech language pathologist, consisting of the battery of isometric / isotonic exercises
Primary Outcome Measure Information:
Title
Change in T2 Weighted Magnetic Resonance Imaging
Description
T2 Weighted Magnetic Resonance Imaging (MRI) to quantify baseline muscle parameters in the oral cavity and pharynx. The regions of interest will be identified on images using axial and coronal planes. Information regarding the muscle volume, composition (fat Vs muscle Vs edema) as reflected by the signal intensity.
Time Frame
at 3 months after treatment
Title
Clinical swallowing Ability
Description
Swallowing ability and method/ type of dietary intake, e.g. Functional Oral Intake Scale score [F.O.I.S] over the study period
Time Frame
baseline, 3 weeks, 6 weeks and 3 months post treatment
Secondary Outcome Measure Information:
Title
Weight
Description
Weight and Body Mass Index will be calculated.
Time Frame
baseline, 3 weeks, 6 weeks and 3 months post treatment
Title
Psychosocial functioning
Description
Domain assessments for, quality of life, pain,and fatigue using the Functional Assessment of Cancer Therapy - Head and Neck (FACT-H/N), Pain Disability Index (PDI), Functional Assessment of Cancer Therapy - Anemia (FACT-An) scale, Multidimensional Fatigue Symptom Inventory (MFSI), Profiles of Mood Scale (POMS) and Center for Epidemiologic Studies Depression Scale(CESD).
Time Frame
baseline and 3 months post treatment
Title
Instrumental swallowing evaluation
Description
Range of swallowing biomechanics measured from endoscopic and fluorographic evaluations.
Time Frame
baseline and 3 months post treatment
Title
Swallowing Quality of Life
Description
Patient perception of effect of swallowing disability - Swallowing Quality of Life (SWAL QOL) score during the study period.
Time Frame
baseline and 3 months post treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Head/Neck cancer of the oropharyngeal or adjacent regions, confirmed by clinical history and exam, with positive cross sectional imaging studies and histopathological biopsy excluding other pathology. Planned external beam radiation therapy No previous history of non-oral feeding for cancer related illness Able to undergo MRI imaging scan Patient and physician agreement to enter the study Exclusion Criteria: Planned extensive surgical intervention Existence of a co-existing neurological or medical disorder known to cause dysphagia Prior radiotherapy or surgery to the head / neck region that could contribute to dysphagia. Previous swallowing therapy within four weeks of randomization Gross tumor involvement of the oral and pharyngeal muscles obviating adequate MRI measurements of the majority of muscles of interest.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Giselle Carnaby-Mann, PhD
Organizational Affiliation
University of Florida
Official's Role
Principal Investigator
Facility Information:
Facility Name
Shands Cancer Center, University of Florida
City
Gainesville
State/Province
Florida
ZIP/Postal Code
32610
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Pharyngocise Dose Response Study

We'll reach out to this number within 24 hrs